LicianPro

Arcellx Inc

ACLX

  • Mkt cap

    $6.73B

  • EV/Sales

    298.5

  • P/E ratio

    —

  • FY2025 Revenue

    $22.29M

  • EPS (9mo ended 2025-09-30)

    −$3.06

  • Gross Margin (FY2025)

    —

  • Profit Margin (FY2025)

    −1027.25%

  • Beta

    —

  • Div yield

    —

  • Sector

    Healthcare

ACLX at a glance

ACLX AI brief

AI

Overview

What matters now, from SEC filings and analyst ratings

Takeaway

A takeaway appears here once the latest filing has been analyzed.

Analysts

Quant grade metrics

Sector-relative grades for valuation, growth, profitability, momentum and revisions

How it works

Financials

Earnings

Ownership

Insiders

Form 4 trades, last 90 days

All trades

No open-market insider buy or sell of ACLX since Aug 20, 2026.

Filings

Latest SEC filings

All filings

No recent SEC filings on file.

News

Latest stored headlines

All news

ACLX — Arcellx Inc · rev $22.3M

ACLX Key Statistics

  • Market Cap: $6.73B
  • P/B Ratio: 16.7

Arcellx Inc latest statements (FY2025)

Latest cached year on this hub. Full ACLX income, balance, and cash tables.

  • Revenue$22.3M
  • Net Income-$228.9M
  • Total Assets$604.0M
  • Free Cash Flow-$212.6M

ACLX FAQ

What industry is ACLX in?

Arcellx Inc (ACLX) is a biotechnology company in the Healthcare sector.

What are ACLX's latest revenue and net income?

Latest cached Arcellx Inc (ACLX) revenue for Dec 31, 2025 was $22.3M. Net income was -$228.9M. Statements: https://lician.com/financials/aclx

What is ACLX's market cap?

Arcellx Inc (ACLX) market capitalization is $6.73B on the latest cached snapshot.

ACLX chart and investment calculator load when you scroll here.